Olema Pharmaceuticals (OLMA) Insider Trading & Ownership $15.43 +0.74 (+5.04%) (As of 07/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Olema Pharmaceuticals (NASDAQ:OLMA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$17.85 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$3.74 M Get OLMA Insider Trade Alerts Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OLMA Insider Buying and Selling by Quarter Ad Monument Traders AllianceThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.See here to see the full details. Olema Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/11/2024Cyrus HarmonDirectorSell5,000$12.26$61,300.00 6/28/2024Cyrus HarmonDirectorSell20,000$10.77$215,400.00 6/3/2024Cyrus HarmonDirectorSell5,000$10.93$54,650.00 5/31/2024Cyrus HarmonDirectorSell15,000$9.41$141,150.00 5/6/2024Cyrus HarmonDirectorSell5,000$10.92$54,600.00 4/30/2024Cyrus HarmonDirectorSell15,000$9.51$142,650.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/28/2024Cyrus HarmonDirectorSell20,000$10.97$219,400.00 2/29/2024Cyrus HarmonDirectorSell25,000$12.41$310,250.00 1/31/2024Cyrus HarmonDirectorSell25,000$12.23$305,750.00 12/6/2023Biocapital Advisors L ParadigmMajor ShareholderBuy100,000$11.60$1,160,000.00 12/5/2023G. Walmsley GrahamDirectorBuy131,870$14.19$1,871,235.30 11/30/2023Cyrus HarmonDirectorSell25,000$12.57$314,250.00 11/21/2023Cyrus HarmonDirectorSell4,192$14.86$62,293.12 11/21/2023Naseem ZojwallaInsiderSell7,461$14.84$110,721.24 11/21/2023Sean BohenCEOSell29,293$14.88$435,879.84 11/8/2023David C MylesInsiderSell200$17.61$3,522.00 11/3/2023David C MylesInsiderSell541$17.51$9,472.91 11/2/2023Cyrus HarmonDirectorSell5,000$15.64$78,200.00 11/1/2023David C MylesInsiderSell6,668$15.02$100,153.36 10/31/2023Cyrus HarmonDirectorSell25,000$12.05$301,250.00 9/29/2023Cyrus HarmonDirectorSell25,000$12.41$310,250.00 9/19/2023David C MylesInsiderSell20,000$12.67$253,400.00 9/12/2023Bvf Partners L P/IlDirectorBuy1,505,932$9.84$14,818,370.88 9/5/2023Cyrus HarmonDirectorSell10,000$11.62$116,200.00 8/31/2023Cyrus HarmonDirectorSell15,000$9.36$140,400.00 (Data available from 1/1/2013 forward) OLMA Insider Trading Activity - Frequently Asked Questions Who is on Olema Pharmaceuticals's Insider Roster? The list of insiders at Olema Pharmaceuticals includes Biocapital Advisors L Paradigm, Bvf Partners L P/Il, Cyrus Harmon, David C Myles, G. Walmsley Graham, Kinney Horn, Naseem Zojwalla, and Sean Bohen. Learn more on insiders at OLMA. What percentage of Olema Pharmaceuticals stock is owned by insiders? 19.40% of Olema Pharmaceuticals stock is owned by insiders. Learn more on OLMA's insider holdings. Which Olema Pharmaceuticals insiders have been buying company stock? The following insiders have purchased OLMA shares in the last 24 months: Biocapital Advisors L Paradigm ($1,160,000.00), Bvf Partners L P/Il ($14,818,370.88), and G. Walmsley Graham ($1,871,235.30). How much insider buying is happening at Olema Pharmaceuticals? Insiders have purchased a total of 1,737,802 OLMA shares in the last 24 months for a total of $17,849,606.18 bought. Which Olema Pharmaceuticals insiders have been selling company stock? The following insiders have sold OLMA shares in the last 24 months: Cyrus Harmon ($2,921,193.12), David C Myles ($366,548.27), Naseem Zojwalla ($110,721.24), and Sean Bohen ($435,879.84). How much insider selling is happening at Olema Pharmaceuticals? Insiders have sold a total of 323,355 Olema Pharmaceuticals shares in the last 24 months for a total of $3,834,342.47 sold. More Insider Trading Tools from MarketBeat Related Companies: XENE Insider Selling IDYA Insider Selling FOLD Insider Selling MLTX Insider Selling ACAD Insider Selling GERN Insider Selling MORF Insider Selling AGIO Insider Selling BHC Insider Selling PTCT Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Selling: When It Matters and When It Doesn'tInsiders Sell These Tech Stocks, but Investors Shouldn’tWhat Does Market Rotation Mean for This Top AI Stock?3 Beaten Down Stocks That Insiders Are Buying3 Insider-Buy Stocks to Add to Your Watchlist Now This page (NASDAQ:OLMA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olema Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olema Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.